← Back
$IOVA All transactions

IOVANCE BIOTHERAPEUTICS, INC.

M

$ Value

$0

Shares

120,000

Price

$0

Filed

Feb 26

Insider

Name

Kirby Daniel Gordon

Title

Chief Commercial Officer

CIK

0002055001

Roles

Officer

Transaction Details

Transaction Date

2026-02-24

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

173,546

Footnotes

Represents the number of shares of the Issuer's common stock underlying performance-based restricted stock units ("PSUs") that have been earned based on the level of achievement of certain financial milestones. The earned PSUs vested on February 24, 2026. | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the PSUs. This is not an open market sale of securities. | Represents the common stock remaining after deducting the common stock withheld for taxes. | Each PSU represents a contingent right to receive one share of the Issuer's common stock. | On February 10, 2025, the Reporting Person was granted an award of up to 150,000 PSUs, which vests in the form of shares of the Issuer's common stock upon the achievement of certain financial milestones. On February 24, 2026, certain financial milestones were met, resulting in the vesting of the PSUs as to 120,000 of the underlying shares and the cancellation of the PSUs as to 30,000 of the underlying shares.

Filing Info

Accession No.

0001104659-26-020613

Form Type

4

Issuer CIK

0001425205

Kirby Daniel Gordon's History

Date Ticker Type Value
2026-03-09 IOVA A $0
2026-02-24 IOVA M $0
2026-02-24 IOVA F $129K
2026-02-24 IOVA M $0
2026-02-10 IOVA M $0
2026-02-10 IOVA F $43K
2026-02-10 IOVA M $0
2025-06-05 IOVA $55K

Other Insiders at IOVA (90d)

Insider Bought Sold Last
BILINSKY IGOR
Chief Operating Officer
2026-03-09
Vogt Frederick G
Interim CEO & General Counsel
2026-03-09
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
2026-03-09
Roche Corleen M.
Chief Financial Officer
2026-03-09
Puri Raj K.
Chief Regulatory Officer
2026-03-09
Kirby Daniel Gordon
Chief Commercial Officer
2026-03-09